Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Tengborn

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Haemostasis|January 1, 1989
Clinical experience with human plasma-derived factor VIIa in patients with hemophilia A and high titer inhibitorsU Hedner, S Bjoern, S S Bernvil, et al.
Thrombosis and Haemostasis|March 11, 1998
The influence of a serine protease inhibitor, nafamostat mesilate, on plasma coagulation, and platelet activation during experimental Extracorporeal Life Support (ECLS)K Mellgren, M Skogby, L G Friberg, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 2, 2002
Overall haemostatic potential can be used for estimation of thrombin-activatable fibrinolysis inhibitor-dependent fibrinolysis in vivo and for possible follow-up of recombinant factor VIIa treatment in patients with inhibitors to factor VIIIJ P Antovic, A Antovic, S He, et al.
Haemostasis|November 1, 1994
D-dimer and thrombin/antithrombin III complex--diagnostic tools in deep venous thrombosis?L Tengborn, S Palmblad, J Wojciechowski, et al.
Annals of the Rheumatic Diseases|May 1, 1991
von Willebrand factor antigen and plasminogen activator inhibitor in giant cell arteritisE Nordborg, R Andersson, L Tengborn, et al.
Thrombosis and Haemostasis|September 29, 1989
Changes of plasma coagulation and fibrinolysis in response to mental stressC Jern, E Eriksson, L Tengborn, et al.
British Journal of Haematology|November 11, 1999
Primary prophylaxis in severe haemophilia should be started at an early age but can be individualizedJ Astermark, P Petrini, L Tengborn, et al.
European Journal of Haematology|November 1, 1995
Effects of Erwinia-asparaginase on the coagulation systemH Carlsson, D Stockelberg, L Tengborn, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|March 1, 1994
High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adultsJ O Johansson, K Landin, L Tengborn, et al.
Thrombosis Research|December 15, 1987
Properties and catabolism of heat treated antithrombin III concentrateL Tengborn, B Frohm, L E Nilsson, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Haemostasis|January 1, 1989
Clinical experience with human plasma-derived factor VIIa in patients with hemophilia A and high titer inhibitorsU Hedner, S Bjoern, S S Bernvil, et al.
Thrombosis and Haemostasis|March 11, 1998
The influence of a serine protease inhibitor, nafamostat mesilate, on plasma coagulation, and platelet activation during experimental Extracorporeal Life Support (ECLS)K Mellgren, M Skogby, L G Friberg, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 2, 2002
Overall haemostatic potential can be used for estimation of thrombin-activatable fibrinolysis inhibitor-dependent fibrinolysis in vivo and for possible follow-up of recombinant factor VIIa treatment in patients with inhibitors to factor VIIIJ P Antovic, A Antovic, S He, et al.
Haemostasis|November 1, 1994
D-dimer and thrombin/antithrombin III complex--diagnostic tools in deep venous thrombosis?L Tengborn, S Palmblad, J Wojciechowski, et al.
Annals of the Rheumatic Diseases|May 1, 1991
von Willebrand factor antigen and plasminogen activator inhibitor in giant cell arteritisE Nordborg, R Andersson, L Tengborn, et al.
Thrombosis and Haemostasis|September 29, 1989
Changes of plasma coagulation and fibrinolysis in response to mental stressC Jern, E Eriksson, L Tengborn, et al.
British Journal of Haematology|November 11, 1999
Primary prophylaxis in severe haemophilia should be started at an early age but can be individualizedJ Astermark, P Petrini, L Tengborn, et al.
European Journal of Haematology|November 1, 1995
Effects of Erwinia-asparaginase on the coagulation systemH Carlsson, D Stockelberg, L Tengborn, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|March 1, 1994
High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adultsJ O Johansson, K Landin, L Tengborn, et al.
Thrombosis Research|December 15, 1987
Properties and catabolism of heat treated antithrombin III concentrateL Tengborn, B Frohm, L E Nilsson, et al.
Pageof 10